# Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer

> **NCT06464965** · PHASE1 · COMPLETED · sponsor: **Zhejiang Provincial People's Hospital** · enrollment: 10 (actual)

## Conditions studied

- Gastric Cancer
- Pancreas Adenocarcinoma

## Interventions

- **BIOLOGICAL:** CB CAR-NK18.2
- **DRUG:** Cyclophosphamide
- **DRUG:** Fludarabine

## Key facts

- **NCT ID:** NCT06464965
- **Lead sponsor:** Zhejiang Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-03
- **Primary completion:** 2025-10-10
- **Final completion:** 2025-12-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-04-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06464965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06464965, "Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06464965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*